# A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects

> **NCT03496506** · PHASE1 · COMPLETED · sponsor: **Actelion** · enrollment: 22 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Selexipag
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT03496506
- **Lead sponsor:** Actelion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-05
- **Primary completion:** 2018-05-10
- **Final completion:** 2018-05-18
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03496506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03496506, "A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03496506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*